Aykut Kürşat Fidan
Research Subjects
Research Interests
Aykut Kürşat Fidan has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Bedriye Büşra Demirel
Department of Nuclear Medicine, Ankara Oncology Research and Training Hospital, Ankara, Turkey
2 shared publications - Gülin Uçmak
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA DR. ABDURRAHMAN YURTASLAN ONKOLOJİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
2 shared publications - Hülya Efetürk
Department of Nuclear Medicine, Dr. Burhan Nalbantoglu State Hospital, Nicosia 99010, Cyprus
2 shared publications - İpEk Öztürk
Department of Nuclear Medicine, Başakşehir Cam and Sakura City Hospital, Istanbul, Turkey
2 shared publications - Semra Demirtaş Şenlik
Department of Nuclear Medicine, University of Health Sciences Türkiye, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Türkiye, Turkey
2 shared publications - Adem Maman
Atatürk Universitesi
1 shared publication
Latest Publications
- Open Access
- 25 February 2025
- Published by Hitit University in Hitit Medical Journal
- Vol. 7 (1) , 45-52
The Diagnostic Accuracy of V/P Scintigraphy in Pulmonary Embolism and Superiority of V/P SPECT to V/P Planar Scintigraphy
Objective: The aim of this retrospective study is to investigate the diagnostic accuracy of planar V/P scintigraphy and V/P single-photon emission computed tomography (SPECT) in patients who referred to our clinic for V/P scintigraphy with prediagnosis of pulmonary embolism (PE), as well as to investigate the contribution of V/P SPECT technique to planar V/P technique. Material and Method: The records of 204 patients, who were preliminarily diagnosed with PE within 1 year, were retrospectively reviewed. In our investigation of the diagnostic accuracy of V/P scintigraphy in for PE, we excluded three patients who only underwent perfusion scintigraphy and 20 patients whose final diagnoses could not be confirmed. This left a total of 181 patients included in the statistical analysis. Furthermore, we evaluated the contribution of SPECT to planar imaging in 48 patients, for whom V/P Scintigraphy were reported as positive and whose final diagnoses confirmed PE. Results: The sensitivity, specificity, negative predictive value, positive predictive value, and accuracy rate of V/P SPECT were calculated as 98%, 94.7%, 99.2%, 87.3%, and 95.6%, respectively. For planar scintigraphy, they were found to be 71.4%, 95.4%, 90%, 85.3%, and 88.9%, respectively. In SPECT, 13 (27.1%) patients who were not compatible with pulmonary embolism (PE) on planar imaging were found to have findings consistent with PE. In nine patients (18.8%), additional defects not observed on planar imaging were identified. Although the goodness of fit with the final diagnosis of both methods was statistically significant, SPECT (95.6%) performed better than planar (88.9%) imaging. Conclusion: Consistent with previous studies, it was found that while both imaging methods were successful, SPECT demonstrated higher diagnostic accuracy than planar scintigraphy in diagnosing PE. Therefore, it can be hypothesized that V/P scintigraphy can be safely deemed the first-choice in the diagnosis of PE.
- 25 February 2025
- Published by Hitit University in Hitit Medical Journal
- Vol. 7 (1) , 45-52
Open AccessThe Diagnostic Accuracy of V/P Scintigraphy in Pulmonary Embolism and Superiority of V/P SPECT to V/P Planar Scintigraphy
Objective: The aim of this retrospective study is to investigate the diagnostic accuracy of planar V/P scintigraphy and V/P single-photon emission computed tomography (SPECT) in patients who referred to our clinic for V/P scintigraphy with prediagnosis of pulmonary embolism (PE), as well as to investigate the contribution of V/P SPECT technique to planar V/P technique. Material and Method: The records of 204 patients, who were preliminarily diagnosed with PE within 1 year, were retrospectively reviewed. In our investigation of the diagnostic accuracy of V/P scintigraphy in for PE, we excluded three patients who only underwent perfusion scintigraphy and 20 patients whose final diagnoses could not be confirmed. This left a total of 181 patients included in the statistical analysis. Furthermore, we evaluated the contribution of SPECT to planar imaging in 48 patients, for whom V/P Scintigraphy were reported as positive and whose final diagnoses confirmed PE. Results: The sensitivity, specificity, negative predictive value, positive predictive value, and accuracy rate of V/P SPECT were calculated as 98%, 94.7%, 99.2%, 87.3%, and 95.6%, respectively. For planar scintigraphy, they were found to be 71.4%, 95.4%, 90%, 85.3%, and 88.9%, respectively. In SPECT, 13 (27.1%) patients who were not compatible with pulmonary embolism (PE) on planar imaging were found to have findings consistent with PE. In nine patients (18.8%), additional defects not observed on planar imaging were identified. Although the goodness of fit with the final diagnosis of both methods was statistically significant, SPECT (95.6%) performed better than planar (88.9%) imaging. Conclusion: Consistent with previous studies, it was found that while both imaging methods were successful, SPECT demonstrated higher diagnostic accuracy than planar scintigraphy in diagnosing PE. Therefore, it can be hypothesized that V/P scintigraphy can be safely deemed the first-choice in the diagnosis of PE.
- 31 May 2022
- Published by Academician Publishing
Cerrahide Nükleer Tıp
Nükleer tıp, hastalıkların tanı, tedavi ve takibinde, çevreye, hastalara ve radyasyon çalışanlarına minimum radyasyon maruziyeti oluşturacak koşullarda, radyoaktif madde ve bileşiklerin uygulandığı bir tıpta uzmanlık dalıdır. Tüm nükleer tıp uygulamalarında beklenen yararın potansiyel radyasyon hasarından yüksek olması mutlaka gözetilmektedir. Nükleer tıp ülkemizde 1972-73 yıllarında anabilim dalı statüsü kazanmış olup tıbbın yanısıra pek çok bilim dalı ile de paydaşlık eden (matematik, fizik, kimya, eczacılık, biyoloji vb.) multidisipliner bir daldır. Nükleer tıpta farklı yollardan uygulanabilen (intravenöz, intraarteriyal, solunum yoluyla, vücut boşluğuna enjeksiyon, oral vb.) radyoaktif madde ve bileşiklerin insan vücudundaki bazı biyokimyasal ve fizyolojik yolaklara katılımı ve/ veya hastalıklı doku/organlarda konsantre olması sağlanır. Bu özelliklerinden dolayı “fonksiyonel görüntüleme”, “moleküler görüntüleme” olarak da anılır. Moleküler düzeyde görüntüleme, biyokimyasal, moleküler ve hücresel düzeyde başlayan hastalıkların, doku, organ ve organ sistemlerinde yapısal ve kalıcı değişiklikler oluşturmadan önce erken tanısına olanak vermesinin yanısıra hastalıkların oluş mekanizmalarının açıklanmasında, koruyucu tedbirler alınmasında ve tedaviye yanıtın takibinde de katkı sağlamaktadır.
- 31 May 2022
- Published by Academician Publishing
Cerrahide Nükleer Tıp
Nükleer tıp, hastalıkların tanı, tedavi ve takibinde, çevreye, hastalara ve radyasyon çalışanlarına minimum radyasyon maruziyeti oluşturacak koşullarda, radyoaktif madde ve bileşiklerin uygulandığı bir tıpta uzmanlık dalıdır. Tüm nükleer tıp uygulamalarında beklenen yararın potansiyel radyasyon hasarından yüksek olması mutlaka gözetilmektedir. Nükleer tıp ülkemizde 1972-73 yıllarında anabilim dalı statüsü kazanmış olup tıbbın yanısıra pek çok bilim dalı ile de paydaşlık eden (matematik, fizik, kimya, eczacılık, biyoloji vb.) multidisipliner bir daldır. Nükleer tıpta farklı yollardan uygulanabilen (intravenöz, intraarteriyal, solunum yoluyla, vücut boşluğuna enjeksiyon, oral vb.) radyoaktif madde ve bileşiklerin insan vücudundaki bazı biyokimyasal ve fizyolojik yolaklara katılımı ve/ veya hastalıklı doku/organlarda konsantre olması sağlanır. Bu özelliklerinden dolayı “fonksiyonel görüntüleme”, “moleküler görüntüleme” olarak da anılır. Moleküler düzeyde görüntüleme, biyokimyasal, moleküler ve hücresel düzeyde başlayan hastalıkların, doku, organ ve organ sistemlerinde yapısal ve kalıcı değişiklikler oluşturmadan önce erken tanısına olanak vermesinin yanısıra hastalıkların oluş mekanizmalarının açıklanmasında, koruyucu tedbirler alınmasında ve tedaviye yanıtın takibinde de katkı sağlamaktadır.
- Open Access
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1115-1122
The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients
The aim of this study was to investigate the contribution of fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in staging of pediatric osteosarcoma patients and also to evaluate the ability of metabolic parameters from the primary tumor to predict tumor necrosis rate (TNR). F-18 FDG-PET/CT imaging was performed in staging 37 pediatric osteosarcoma patients. The metabolic parameters SUVmax (maximum standardised uptake value), MTV (metabolic tumour volume) and TLG (total lesion glycolysis) were measured from the primary tumor. TNR level of the primary tumor was histopathologically measured after standard neoadjuvant chemotherapy treatment. The contribution of F-18 FDG-PET/CT to staging of pediatric osteosarcoma patients and the accuracy of metabolic parameters of the primary tumor to predict TNR were analized by regression analysis. MTV and TLG of the primary tumor were found to efficiently predict histopathologic TNR, whereas SUVmax was not (p=0.012, p=0.027, p=0.25, respectively). Also 5 of 12 patients (41.6%) who were initially defined as localised osteosarcoma were upstaged in consequence of staging F-18 FDG-PET/CT findings. F-18 FDG-PET/CT staging in pediatric osteosarcoma patients can effectively distinguish metastatic-localised disease. MTV and TLG values are important parameters which can efficiently be used to predict TNR.
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1115-1122
Open AccessThe relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients
The aim of this study was to investigate the contribution of fluorine-18 (F-18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging in staging of pediatric osteosarcoma patients and also to evaluate the ability of metabolic parameters from the primary tumor to predict tumor necrosis rate (TNR). F-18 FDG-PET/CT imaging was performed in staging 37 pediatric osteosarcoma patients. The metabolic parameters SUVmax (maximum standardised uptake value), MTV (metabolic tumour volume) and TLG (total lesion glycolysis) were measured from the primary tumor. TNR level of the primary tumor was histopathologically measured after standard neoadjuvant chemotherapy treatment. The contribution of F-18 FDG-PET/CT to staging of pediatric osteosarcoma patients and the accuracy of metabolic parameters of the primary tumor to predict TNR were analized by regression analysis. MTV and TLG of the primary tumor were found to efficiently predict histopathologic TNR, whereas SUVmax was not (p=0.012, p=0.027, p=0.25, respectively). Also 5 of 12 patients (41.6%) who were initially defined as localised osteosarcoma were upstaged in consequence of staging F-18 FDG-PET/CT findings. F-18 FDG-PET/CT staging in pediatric osteosarcoma patients can effectively distinguish metastatic-localised disease. MTV and TLG values are important parameters which can efficiently be used to predict TNR.